Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

ICVX

Company AnnouncementsIcosavax Acquisition by AstraZeneca Leads to Delisting and Corporate Changes

7M ago

ICVX

PremiumThe Fly

Icosavax downgraded to Neutral from Buy at Guggenheim

9M ago

AZN

ICVX

PremiumThe Fly

Icosavax just downgraded at Jefferies, here’s why

9M ago

ICVX

PremiumThe Fly

Icosavax just downgraded at William Blair, here’s why

9M ago

ICVX

PremiumMarket News

M & A News: AstraZeneca’s (NASDAQ:AZN) $1.1B Bet on ICVX Sends Shares Soaring

9M ago

AZN

ICVX

PremiumThe FlyIcosavax announces interim results from IVX-A12 trial

9M ago

ICVX

Icosavax to be acquired by AstraZeneca for $15.00 per share in cash, CVR

Premium

The Fly

Icosavax to be acquired by AstraZeneca for $15.00 per share in cash, CVR

9M ago

AZN

ICVX

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca

Premium

Press Releases

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca

9M ago

ICVX

PremiumThe Fly

Icosavax initiated with a Buy at Guggenheim

10M ago

ICVX

PremiumThe Fly

Icosavax reports Q3 EPS (44c), consensus (57c)

10M ago

ICVX

PremiumPre-Earnings

Icosavax, Inc. (ICVX) Q3 Earnings Cheat Sheet

10M ago

ICVX

PremiumPress Releases

Icosavax to Participate in the Jefferies London Healthcare Conference

11M ago

ICVX

Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference

PremiumPress ReleasesIcosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference

11M ago

ICVX

Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023

Premium

Press Releases

Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023

1y ago

ICVX

Icosavax reports Q2 EPS (59c), consensus (60c)

Premium

The Fly

Icosavax reports Q2 EPS (59c), consensus (60c)

1y ago

ICVX

PremiumPress Releases

Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update

1y ago

ICVX

PremiumThe Fly

Icosavax reports immunogenicity data on VLP vaccine IVX-121 for RSV

1y ago

ICVX

PremiumThe Fly

Icosavax initiates Phase 2 trial of IVX-A12 against RSV, hMPV

1y ago

ICVX

PremiumPress Releases

Icosavax Announces $67.8 Million Registered Direct Offering of Common Stock

1y ago

ICVX

Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults

PremiumPress ReleasesIcosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults

1y ago

ICVX

Icosavax reports Q4 EPS (59c), consensus (59c)

Premium

The Fly

Icosavax reports Q4 EPS (59c), consensus (59c)

1y ago

ICVX

Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Premium

Press Releases

Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

1y ago

ICVX

ICVX

Trending

Indices

Stocks

ETFs